126 related articles for article (PubMed ID: 19032521)
1. Changes in interventional treatment--from the viewpoint of percutaneous ethanol injection therapy.
Kitaoka M
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S16-20. PubMed ID: 19032521
[TBL] [Abstract][Full Text] [Related]
2. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
3. [Chronic kidney disease (CKD) and bone. The clinical perspective of parathyroid interventional therapy for advanced secondary hyperparathyroidism in the era of cinacalcet HCl].
Tominaga Y
Clin Calcium; 2009 Apr; 19(4):545-50. PubMed ID: 19329834
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
[TBL] [Abstract][Full Text] [Related]
5. [Significance of point of no return in therapeutic strategy for treatment of renal osteodystrophy; from histopathological findings].
Koiwa F; Hirose M
Clin Calcium; 2004 Sep; 14(9):46-52. PubMed ID: 15577109
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
7. [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)].
Tanaka M; Itoh K; Matsushita K; Ogawa A; Hirayama H; Tsunoda N; Yoshizumi K; Naruse M; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):409-13. PubMed ID: 12073627
[TBL] [Abstract][Full Text] [Related]
8. [Ultrasonography-guided therapeutic procedures in the neck region].
Brzac HT
Acta Med Croatica; 2009 Dec; 63 Suppl 3():21-7. PubMed ID: 20235370
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.
Komaba H; Shiizaki K; Fukagawa M
Expert Opin Biol Ther; 2010 Dec; 10(12):1729-42. PubMed ID: 21058933
[TBL] [Abstract][Full Text] [Related]
10. Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.
Yamada S; Taniguchi M; Tokumoto M; Tsuruya K; Hirakata H; Iida M
Ther Apher Dial; 2010 Aug; 14(4):424-31. PubMed ID: 20649764
[TBL] [Abstract][Full Text] [Related]
11. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy.
Chen HH; Hsu MT; Wu CJ; Chen YW; Yang TL
Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687
[TBL] [Abstract][Full Text] [Related]
12. Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics.
Tominaga Y; Matsuoka S; Uno N; Sato T
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S21-6. PubMed ID: 19032523
[TBL] [Abstract][Full Text] [Related]
13. [Parathyroid gland intervention therapy for patients with secondary hyperparathyroidism due to dialysis].
Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S
Clin Calcium; 2005 Sep; 15 Suppl 1():185-91. PubMed ID: 16279023
[No Abstract] [Full Text] [Related]
14. [Secondary hyperparathyroidism].
Imanishi Y; Inaba M
Nihon Rinsho; 2006 Jun; Suppl 2():31-6. PubMed ID: 16817344
[No Abstract] [Full Text] [Related]
15. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
Yamamoto H; Katoh N; Takeyama H; Ikeda M; Yokoyama K; Shigematsu T; Kawaguchi Y; Hosoya T
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii50-2. PubMed ID: 12771301
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients.
Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S11-5. PubMed ID: 16109135
[TBL] [Abstract][Full Text] [Related]
17. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland.
Yumita S
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii62-4. PubMed ID: 12771304
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism.
Douthat WG; Orozco SE; Maino P; Cardozo G; de Arteaga J; de la Fuente J; Chiurchiu CR; Massari PU
Transpl Int; 2007 Dec; 20(12):1031-5. PubMed ID: 17883371
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
Iseki K
Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
[TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism caused by distant pulmonary lesions and parathyromatosis after ethanol injection/parathyroidectomy for secondary hyperparathyroidism.
Nakamura M; Tanaka K; Fujii T
Hemodial Int; 2017 Jul; 21(3):E45-E49. PubMed ID: 28078796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]